Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Van Hemelrijck, Mieke"'
Autor:
Monroy-Iglesias MJ; Translational Oncology and Urology Research, King's College London, London, UK maria.j.monroy_iglesias@kcl.ac.uk., Martin S; Medical Oncology, Guy's and St Thomas' Hospitals NHS Trust, London, UK., Cargaleiro C; Medical Oncology, Guy's and St Thomas' Hospitals NHS Trust, London, UK., Jones G; Medical Oncology, Guy's and St Thomas' Hospitals NHS Trust, London, UK.; Southeast London Cancer Alliance, London, UK., Steward L; Medical Oncology, Guy's and St Thomas' Hospitals NHS Trust, London, UK., Murtagh C; Medical Oncology, Guy's and St Thomas' Hospitals NHS Trust, London, UK., Bruno F; Medical Oncology, Guy's and St Thomas' Hospitals NHS Trust, London, UK., Millwaters J; Medical Oncology, Guy's and St Thomas' Hospitals NHS Trust, London, UK., Schizas A; Department of Colorectal Surgery, Guy's and St Thomas' NHS Foundation Trust, London, UK., Watson H; Department of Colorectal Surgery, Guy's and St Thomas' NHS Foundation Trust, London, UK., Haire A; Translational Oncology and Urology Research, King's College London, London, UK., Haire K; Southeast London Cancer Alliance, London, UK., Moss CL; Translational Oncology and Urology Research, King's College London, London, UK., Russell B; Translational Oncology and Urology Research, King's College London, London, UK., Srirajaskanthan R; Department of Gastroenterology, King's College Hospital, London, UK., Van Hemelrijck M; Translational Oncology and Urology Research, King's College London, London, UK., Dolly S; Medical Oncology, Guy's and St Thomas' Hospitals NHS Trust, London, UK.
Publikováno v:
BMJ open [BMJ Open] 2024 Apr 15; Vol. 14 (4), pp. e080285. Date of Electronic Publication: 2024 Apr 15.
Autor:
Wong K; Urology, The Royal Marsden NHS Foundation Trust, London, UK kathie.wong2@nhs.net.; Urology, North Cumbria Integrated Care NHS Foundation Trust, Carlisle, UK., Kinsella N; Urology, The Royal Marsden NHS Foundation Trust, London, UK., Seth J; Urology, St George's Hospital, London, UK., Nicol D; Urology, The Royal Marsden NHS Foundation Trust, London, UK., Cahill D; Urology, The Royal Marsden NHS Foundation Trust, London, UK., Kasivisvanathan R; Department of Surgery and Anaesthesia, Royal Marsden NHS Foundation Trust, London, UK., Withington J; Urology, University College London, London, UK., Moghul M; Urology, The Royal Marsden NHS Foundation Trust, London, UK., Moss CL; Translational Oncology and Urology Research, King's College London, London, UK., Van Hemelrijck M; Translational Oncology and Urology Research, King's College London, London, UK., Giorgakoudi K; City, University of London, London, UK.; NIHR Biomedical Research Centre at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research UK, London, UK., Cottrell C; Urology, The Royal Marsden NHS Foundation Trust, London, UK., Yates E; Royal Marsden Hospital NHS Trust, London, UK., Khoo V; Department of Oncology, Royal Marsden NHS Foundation Trust, London, UK.; Institute of Cancer Research Division of Cancer Therapeutics, London, UK., James ND; Department of Oncology, Royal Marsden NHS Foundation Trust, London, UK.; Division of Radiotherapy and Imaging, Institute of Cancer Research, London, UK.
Publikováno v:
BMJ open [BMJ Open] 2023 Oct 06; Vol. 13 (10), pp. e076621. Date of Electronic Publication: 2023 Oct 06.
Autor:
Beyer K; Translational and Oncology Research (TOUR), King's College London, Faculty of Life Sciences and Medicine, London, UK katharina.beyer@kcl.ac.uk., Moris L; Department of Urology, University Hospitals Leuven, Leuven, Belgium., Lardas M; Department of Urology, Metropolitan Hospital, Athens, Greece., Haire A; Translational and Oncology Research (TOUR), King's College London, Faculty of Life Sciences and Medicine, London, UK., Barletta F; Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milan, Italy., Scuderi S; Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milan, Italy., Molnar M; Bayer AG, Berlin, Germany., Herrera R; Bayer AG, Berlin, Germany., Rauf A; Department of Urology, Mid Cheshire Hospitals, NHS Foundation Trust, Crewe, UK., Campi R; Department of Minimally Invasive and Robotic Urologic Surgery and Kidney Transplantation, University of Florence, Florence, Italy., Greco I; Department of Minimally Invasive and Robotic Urologic Surgery and Kidney Transplantation, University of Florence, Florence, Italy., Shiranov K; CDC Zdorovie, Rostov-on-Don, Russia., Dabestani S; Dept. of Translational Medicine, Division of Urological Cancers, Lund University, Kristianstad Central Hospital, Malmo, Sweden., van den Broeck T; Department of Urology, University Hospitals Leuven, Leuven, Belgium., Arun S; Flatiron Health, London, UK., Gacci M; Department of Minimally Invasive and Robotic Urologic Surgery and Kidney Transplantation, University of Florence, Florence, Italy., Gandaglia G; Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milan, Italy., Omar MI; Academic Urology Unit, University of Aberdeen, Aberdeen, UK., MacLennan S; Academic Urology Unit, University of Aberdeen, Aberdeen, UK., Roobol MJ; Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands., Farahmand B; Global Epidemiology, Bayer AG, Stockholm, Sweden., Vradi E; Bayer AG, Berlin, Germany., Devecseri Z; Sanofi, Paris, France., Asiimwe A; Bayer AG, Berlin, Germany., Zong J; Global Medical Affairs Oncology, Real World Evidence, Bayer HealthCare Pharmaceuticals Inc, Whippany, New Jersey, USA., Maclennan SJ; Academic Urology Unit, University of Aberdeen, Aberdeen, UK., Collette L; EORTC Headquarters, Brussels, Belgium., NDow J; Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands., Briganti A; Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.; Department of Urology, University Vita e Salute-San Raffaele, Milan, Italy., Bjartell A; Department of Translational Medicine, Lund University, Malmö, Sweden., Van Hemelrijck M; Translational and Oncology Research (TOUR), King's College London, Faculty of Life Sciences and Medicine, London, UK.
Publikováno v:
BMJ open [BMJ Open] 2022 Apr 04; Vol. 12 (4), pp. e058267. Date of Electronic Publication: 2022 Apr 04.
Autor:
Iya AM; Urology Unit, Aminu Kano Teaching Hospital, Kano, Nigeria., Beyer K; Translational Oncology and Urology Research, King's College London, London, UK., Kotecha P; Translational Oncology and Urology Research, King's College London, London, UK., Kibaru J; Translational Oncology and Urology Research, King's College London, London, UK., Abdullahi M; Urology Unit, Aminu Kano Teaching Hospital, Kano, Nigeria.; Urology, Bayero University College of Health Sciences, Kano, Nigeria., Alhassan SU; Urology Unit, Aminu Kano Teaching Hospital, Kano, Nigeria., Mustapha MI; Oncology Unit, Radiology Department, Aminu Kano Teaching Hospital, Kano, Nigeria., Ahmad A; Pathology, Aminu Kano Teaching Hospital, Kano, Nigeria., Lawal Y; Radiology Department, Aminu Kano Teaching Hospital, Kano, Nigeria., Rabiu Ibrahim J; Community Medicine, Aminu Kano Teaching Hospital, Kano, Nigeria., Aminu A; Microbiology, Aminu Kano Teaching Hospital, Kano, Nigeria., Abubakar A; Pharmacy, Aminu Kano Teaching Hospital, Kano, Nigeria., Saleh A; Nursing department, Aminu Kano Teaching Hospital, Kano, Nigeria., Bryan RT; Bladder Cancer Research Centre, Institute of Cancer & Genomic Sciences, University of Birmingham, Birmingham, UK., Van Hemelrijck M; Translational Oncology and Urology Research, King's College London, London, UK., Russell B; Translational Oncology and Urology Research, King's College London, London, UK beth.russell@kcl.ac.uk.
Publikováno v:
BMJ open [BMJ Open] 2022 Mar 08; Vol. 12 (3), pp. e049241. Date of Electronic Publication: 2022 Mar 08.
Autor:
Chen M; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Raj R; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Fox L; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Moss CL; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., George G; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Karagiannis SN; St John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, London, UK.; Breast Cancer Now Research Unit, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Enting D; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; Department of Medical Oncology, Guy's and Saint Thomas' NHS Foundation Trust, London, UK., Joseph M; Immunobiology, School of Immunology & Microbial Sciences, King's College London, London, UK., Peat N; Guy's and St Thomas' NHS Foundation Trust, London, UK., Russell B; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK beth.russell@kcl.ac.uk., Van Hemelrijck M; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.
Publikováno v:
BMJ open [BMJ Open] 2021 Oct 08; Vol. 11 (10), pp. e046052. Date of Electronic Publication: 2021 Oct 08.
Autor:
Marsden T; Division of Surgical and Interventional Sciences, University College London, London, UK teresa.marsden@ucl.ac.uk.; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK., Lomas DJ; Department of Urology, Mayo Clinic, Rochester, New York, USA., McCartan N; Division of Surgical and Interventional Sciences, University College London, London, UK.; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK., Hadley J; Division of Surgical and Interventional Sciences, University College London, London, UK.; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK., Tuck S; ReIMAGINE Consortium Patient Representative, University College London, London, UK., Brown L; MRC Clinical Trials Unit, University College London, London, UK., Haire A; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Moss CL; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Green S; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Van Hemelrijck M; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Coolen T; London Institute for Mathematical Sciences, London, UK., Santaolalla A; Cancer Epidemiology Group, Division of Cancer Studies, King's College London, London, UK., Isaac E; Centre for Medical Imaging, University College London, London, UK., Brembilla G; Centre for Medical Imaging, University College London, London, UK., Kopcke D; Department of Radiology, University College London Hospitals NHS Foundation Trust, London, UK., Giganti F; Division of Surgical and Interventional Sciences, University College London, London, UK.; Department of Radiology, University College London Hospitals NHS Foundation Trust, London, UK., Sidhu H; Centre for Medical Imaging, University College London, London, UK., Punwani S; Centre for Medical Imaging, University College London, London, UK., Emberton M; Division of Surgical and Interventional Sciences, University College London, London, UK.; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK., Moore CM; Division of Surgical and Interventional Sciences, University College London, London, UK.; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK.
Publikováno v:
BMJ open [BMJ Open] 2021 Sep 30; Vol. 11 (9), pp. e048144. Date of Electronic Publication: 2021 Sep 30.
Autor:
Bessa A; Translational Oncology Urology Research, King's College London, London, UK., Bosco C; Faculty of Life Sciences and Medicine, King's College London, London, UK., Mehrotra S; Translational Oncology Urology Research, King's College London, London, UK., Rowland M; King's College London - Strand Campus, London, London, UK., Zhang H; King's College London - Strand Campus, London, London, UK., Russell B; King's College London - Strand Campus, London, London, UK., Fox L; Translational Oncology Urology Research, King's College London, London, UK., Beyer K; King's College London - Strand Campus, London, London, UK., Rammant E; Ghent University, Ghent, Belgium., Amery S; Guy's and St Thomas' NHS Foundation Trust, London, UK., Chatterton K; Guy's and St Thomas' NHS Foundation Trust, London, UK., Peat N; Guy's and St Thomas' NHS Foundation Trust, London, UK., Haggstrom C; Uppsala Universitet, Uppsala, Sweden., Van Hemelrijck M; Translational Oncology Urology Research, King's College London, London, UK.
Publikováno v:
BMJ open sport & exercise medicine [BMJ Open Sport Exerc Med] 2021 Mar 10; Vol. 7 (1), pp. e000951. Date of Electronic Publication: 2021 Mar 10 (Print Publication: 2021).
Autor:
Dettorre GM; Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK., Dolly S; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Loizidou A; Department of Infectious Diseases, Internal Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Chester J; Medical Oncology, School of Medicine, Cardiff University, Cardiff, UK.; Medical Oncology, Velindre Cancer Centre, Cardiff, UK., Jackson A; Clinical Trials, Velindre Cancer Centre, Cardiff, UK., Mukherjee U; Medical Oncology, Barts Health NHS Trust, London, UK., Zambelli A; Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy., Aguilar-Company J; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain.; Infectious Diseases, Vall d'Hebron University Hospital, Barcelona, Spain., Bower M; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK., Sng CCT; Cancer Division, University College London Hospitals, London, UK., Salazar R; Department of Medical Oncology, ICO L'Hospitalet, Oncobell Program (IDIBELL), CIBERONC, Hospitalet de Llobregat, Spain., Bertuzzi A; Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center - IRCCS, Rozzano, Milan, Italy., Brunet J; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Mesia R; Department of Medical Oncology, Catalan Institute of Oncology, Badalona, Spain., Sita-Lumsden A; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Seguí E; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain., Biello F; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale and Maggiore della Carità Hospital, Novara, Italy., Generali D; Multidisciplinary Breast Pathology and Translational Research Unit, ASST Cremona, Cremona, Italy.; Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy., Grisanti S; Medical Oncology Unit, Spedali Civili, Brescia, Italy., Seeva P; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Rizzo G; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Libertini M; Medical Oncology Unit, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy., Maconi A; Infrastruttura Ricerca Formazione Innovazione, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy., Moss C; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Russell B; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Harbeck N; Department of Gynecology and Obstetrics, Breast Center and Gynecological Cancer Center and CCC Munich, University Hospital Munich, Munich, Germany., Vincenzi B; Medical Oncology, Policlinico Universitario Campus Bio-Medico, Rome, Italy., Bertulli R; Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Ottaviani D; Cancer Division, University College London Hospitals, London, UK., Liñan R; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Marrari A; Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center - IRCCS, Rozzano, Milan, Italy., Carmona-García MC; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Chopra N; Cancer Division, University College London Hospitals, London, UK., Tondini CA; Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy., Mirallas O; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain., Tovazzi V; Medical Oncology Unit, Spedali Civili, Brescia, Italy., Fotia V; Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy., Cruz CA; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain., Saoudi-Gonzalez N; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain., Felip E; Department of Medical Oncology, Catalan Institute of Oncology, Badalona, Spain., Roqué A; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Lee AJX; Cancer Division, University College London Hospitals, London, UK., Newsom-Davis T; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK., García-Illescas D; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain., Reyes R; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain., Wong YNS; Cancer Division, University College London Hospitals, London, UK., Ferrante D; Department of Translational Medicine, Unit of Cancer Epidemiology, CPO-Piemonte, University of Eastern Piedmont, Novara, Italy., Scotti L; Department of Translational Medicine, Unit of Cancer Epidemiology, CPO-Piemonte, University of Eastern Piedmont, Novara, Italy., Marco-Hernández J; Department of Internal Medicine, Hospital Clinic, Barcelona, Spain., Ruiz-Camps I; Infectious Diseases, Vall d'Hebron University Hospital, Barcelona, Spain., Patriarca A; Division of Haematology, Department of Translational Medicine, University of Piemonte Orientale and Maggiore della Carità Hospital, Novara, Italy., Rimassa L; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini, 20090 Pieve Emanuele, Milan, Italy., Chiudinelli L; Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy., Franchi M; Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy., Santoro A; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini, 20090 Pieve Emanuele, Milan, Italy., Prat A; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain., Gennari A; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale and Maggiore della Carità Hospital, Novara, Italy., Van Hemelrijck M; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK.; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Tabernero J; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), IOB-Quiron, UVic-UCC, Barcelona, Spain., Diamantis N; Medical Oncology, Barts Health NHS Trust, London, UK., Pinato DJ; Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK david.pinato@imperial.ac.uk.; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale and Maggiore della Carità Hospital, Novara, Italy.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Mar; Vol. 9 (3).
Autor:
Beyer K; Translational Oncology and Urology Research (TOUR), King's College London, London, UK katharina.beyer@kcl.ac.uk., Moris L; Department of Urology, KU Leuven University Hospitals Leuven, Leuven, Flanders, Belgium., Lardas M; Department of Urology, Metropolitan Hospital Athens, Athens, Attike, Greece., Haire A; Translational Oncology and Urology Research (TOUR), King's College London, London, UK., Barletta F; Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milano, Lombardia, Italy., Scuderi S; Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milano, Lombardia, Italy., Vradi E; Medical Affairs and PV, Bayer Pharma AG, Berlin, Germany., Gandaglia G; Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milano, Lombardia, Italy., Omar MI; Academic Urology Unit, Health Services Research Unit, University of Aberdeen, Aberdeen, Aberdeen, UK., MacLennan S; Academic Urology Unit, Health Services Research Unit, University of Aberdeen, Aberdeen, Aberdeen, UK., Zong J; Epidemiology, Bayer U.S, Whippany, New Jersey, USA., Farahmand B; Global Epidemiology, Bayer AG, Stockholm, Sweden., Maclennan SJ; Academic Urology Unit, Health Services Research Unit, University of Aberdeen, Aberdeen, Aberdeen, UK., Devecseri Z; Sanofi SA, Paris, Île-de-France, France., Asiimwe A; Medical Affairs and PV, Bayer Pharma AG, Berlin, Germany., Collette L; EORTC, Brussels, Belgium., Bjartell A; Skåne University Hospital, Malmö, Sweden., Ndow J; Guidelines Office, European Association of Urology, Arnhem, Netherlands., Briganti A; Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milano, Lombardia, Italy.; Department of Urology and Division of Experimental Oncology, Urological Research Institute, Vita-Salute University San Raffaele, RCCS San Raffaele Scientific Institute, Milan, Italy., Van Hemelrijck M; Translational Oncology and Urology Research (TOUR), King's College London, London, UK.
Publikováno v:
BMJ open [BMJ Open] 2021 Feb 11; Vol. 11 (2), pp. e040531. Date of Electronic Publication: 2021 Feb 11.
Scoping review protocol: bladder cancer in Nigeria: what are the gaps in clinical care and research?
Autor:
Kibaru J; Faculty of Life Sciences and Medicine, Translational Oncology and Urology Research, King's College London, London, UK joyce.w.kibaru@kcl.ac.uk., Kotecha P; Faculty of Life Sciences and Medicine, Translational Oncology and Urology Research, King's College London, London, UK., Iya AM; Urology Unit, Department of Surgery, Aminu Kano Teaching Hospital, Kano, Nigeria., Russell B; Faculty of Life Sciences and Medicine, Translational Oncology and Urology Research, King's College London, London, UK., Abdullahi M; Urology Unit, Department of Surgery, Aminu Kano Teaching Hospital, Kano, Nigeria., Alhassan SU; Urology Unit, Department of Surgery, Aminu Kano Teaching Hospital, Kano, Nigeria., Mustapha MI; Clinical and Radiation Oncology Unit, Radiology Department, Aminu Kano Teaching Hospital, Kano, Nigeria., Bryan RT; Bladder Cancer Group, Institute of Cancer & Genomic Sciences, University of Birmingham, Birmingham, UK., Van Hemelrijck M; Faculty of Life Sciences and Medicine, Translational Oncology and Urology Research, King's College London, London, UK.
Publikováno v:
BMJ open [BMJ Open] 2021 Jan 31; Vol. 11 (1), pp. e041894. Date of Electronic Publication: 2021 Jan 31.